No Data
No Data
中國同輻:2023年度報告
Changes in Hong Kong stocks | China Tongshi (01763) rose more than 4%, China Nuclear Qualcomm officially has the capacity to produce and supply Nuclides such as Wancuri GMP grade N-177
The Zhitong Finance App learned that China's Tongbo (01763) rose by more than 4%. As of press release, it had risen 3.85% to HK$10.26, with a turnover of HK$1,228,800. According to the news, the China Communications Agency announced that recently, the first domestic production line with an annual output of Wanjuli grade Carrier-free Zi-177 GMP and an annual production capacity of 1,000 germanium 68Ge-68Ga generators was fully completed and put into operation, marking the actual realization of large-scale commercialization of the two GMP-grade GMP-grade GE-177 and Gallium-68 medical nuclides. The smooth commissioning of the production line will effectively mitigate domestic supply shortages of Zn-177 and Gallium-68
China Tongfu announced on the Hong Kong Stock Exchange recently that the first domestic production line with an annual output of 10,000 Juri—grade carrier-free GM—177GMP production line, with an annual production capacity of 1,000-grade germanium and gall
China Tongfu announced on the Hong Kong Stock Exchange recently that the first domestic production line with an annual output of 10,000 Juri—grade carrier-free GM—177GMP production line, with an annual production capacity of 1,000-grade germanium and gallium-68Ga, has been fully completed and put into operation, marking the actual realization of large-scale commercialization of the two types of GMP grade -177 and gallium-68 medical nuclides. The smooth commissioning of the production line will effectively mitigate the problem of insufficient domestic supply of Zn-177 and Gallium-68, which is heavily dependent on imports.
China Tongshi (01763.HK): CNNC Qualcomm officially has the capacity to produce and supply Nuclides such as Wancuri GMP grade -177
Gelonghui, April 22 | China Tongzhu (01763.HK) announced that recently, the first domestic-produced Wanjuli grade carrier-free -177 GMP production line, with an annual production capacity of 1,000 germanium gallium 68Ge-68Ga generators, has been fully completed and put into operation, marking the actual realization of the large-scale commercial supply of GMP-grade GMP-grade GE-177 and Gallium-68 medical nuclides.
Changes in Hong Kong stocks | China Tongshi (01763) rose more than 7% intraday to achieve full localization of carbon-14 isotopes supply
China Tongshi (01763) rose more than 7% in the intraday period. As of press release, it rose 6.49% to HK$9.85, with a turnover of HK$3.564,400.
Hong Kong Stock Concept Tracking | China's first mass production of carbon-14 isotope domestically produced nuclear drugs ushered in new opportunities (with concept stocks)
At 13:48 on April 20, after two years of core irradiation, the first carbon-14 target was successfully removed from the Qinshan Nuclear Power Heavy Water Reactor Unit of China Nuclear Power Investment Holdings under the China Nuclear Power Group. This was the first time that China mass-produced carbon-14 isotopes, solving the problem that domestic carbon-14 isotopes are dependent on imports, and fully localizing carbon-14 supply. Carbon-14 is a radioactive isotope of carbon and is widely used as a tracer. Helicobacter pylori testing is its most representative use. In addition, fields such as pharmacokinetic research and beta-ray environmental monitoring systems also require carbon-14. Previously
No Data